Hepion Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HEPA and other ETFs, options, and stocks.

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. 

CEO
John Patrick Brancaccio
CEOJohn Patrick Brancaccio
Employees
—
Employees—
Headquarters
Morristown, New Jersey
HeadquartersMorristown, New Jersey
Founded
2013
Founded2013
Employees
—
Employees—

HEPA Key Statistics

Market cap
3.08M
Market cap3.08M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
3.76M
Average volume3.76M
High today
$0.31
High today$0.31
Low today
$0.2807
Low today$0.2807
Open price
$0.2906
Open price$0.2906
Volume
546.30K
Volume546.30K
52 Week high
$1.59
52 Week high$1.59
52 Week low
$0.0203
52 Week low$0.0203
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.